Open Access<p>Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]</p>
Author(s) -
Richard Hodgson
Publication year - 2019
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s228414
Subject(s) - aripiprazole , paliperidone palmitate , medicine , paliperidone , pharmacology , psychiatry , schizophrenia (object oriented programming) , risperidone